Cwm LLC Raises Stock Position in Tenet Healthcare Corporation $THC

Cwm LLC lifted its position in Tenet Healthcare Corporation (NYSE:THC) by 150.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,483 shares of the company’s stock after purchasing an additional 27,320 shares during the period. Cwm LLC owned 0.05% of Tenet Healthcare worth $9,235,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in THC. ProShare Advisors LLC increased its stake in shares of Tenet Healthcare by 1.7% during the second quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after buying an additional 67 shares during the period. Quadcap Wealth Management LLC grew its holdings in Tenet Healthcare by 1.7% during the 2nd quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock worth $721,000 after acquiring an additional 69 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Tenet Healthcare by 2.8% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company’s stock valued at $460,000 after purchasing an additional 70 shares in the last quarter. Signaturefd LLC lifted its position in shares of Tenet Healthcare by 11.2% in the 2nd quarter. Signaturefd LLC now owns 732 shares of the company’s stock worth $129,000 after purchasing an additional 74 shares during the period. Finally, Vista Investment Partners LLC increased its holdings in Tenet Healthcare by 0.3% during the second quarter. Vista Investment Partners LLC now owns 25,257 shares of the company’s stock valued at $4,445,000 after buying an additional 76 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

THC has been the topic of several recent research reports. KeyCorp increased their target price on Tenet Healthcare from $205.00 to $225.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Wells Fargo & Company upped their price objective on Tenet Healthcare from $238.00 to $252.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Royal Bank Of Canada lifted their target price on Tenet Healthcare from $230.00 to $252.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Morgan Stanley restated an “overweight” rating and issued a $247.00 price target on shares of Tenet Healthcare in a report on Thursday, December 18th. Finally, Barclays boosted their price objective on shares of Tenet Healthcare from $229.00 to $240.00 and gave the stock an “overweight” rating in a research note on Friday, November 21st. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $231.81.

Insider Transactions at Tenet Healthcare

In related news, Director Tammy Romo sold 645 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $205.20, for a total value of $132,354.00. Following the transaction, the director owned 34,866 shares in the company, valued at approximately $7,154,503.20. This represents a 1.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total transaction of $521,075.00. Following the sale, the director owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 45,500 shares of company stock worth $9,247,071 in the last ninety days. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Up 0.2%

NYSE:THC opened at $200.97 on Tuesday. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27. The firm has a fifty day simple moving average of $203.21 and a 200-day simple moving average of $187.89. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $222.82. The company has a market capitalization of $17.66 billion, a P/E ratio of 13.77, a PEG ratio of 0.88 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.33 by $0.37. The company had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the business posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, equities research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.